The diagnosis of myelodysplastic syndromes (MDS) requires a high clinical index of
suspicion to prompt bone marrow studies as well as subjective assessment of dysplastic …

Introduction Myelodysplastic syndromes (MDS) are characterized by morphologic dysplasia
and cytopenia and have a propensity for acute leukemic transformation. However, dysplasia …

Dear editors, Dysplasia of granulocytes in PB morphology may be an important step toward
diagnosis of myelodysplastic syndrome (MDS). 1, 2 Dysplasia of blood cells can be detected …

Simple Summary A substantial fraction of the elderly population suffers from moderate
anemia, and blood smear analysis can guide towards a diagnosis of myelodysplastic …

Aims Given the time, expense and clinical expertise required for a myelodysplastic
syndrome (MDS) diagnosis, there is a clear need for a cost-effective screening laboratory …

Myelodysplastic syndromes (MDSs) are clonal hematopoietic diseases of the elderly,
characterized by chronic cytopenia, ineffective and dysplastic hematopoiesis, recurrent …

The diagnosis of myelodysplastic syndromes (MDS) is often challenging, time‐and resource‐
consuming. A thorough analysis of complete blood count (CBC) parameters could, however …

A non-invasive myelodysplastic syndromes (MDS) diagnostic model would allow for care
while avoiding invasive bone marrow examinations (BME). BME-established MDS patients …

Objectives Myelodysplastic syndromes (MDS) are a group of myeloid neoplasms that are
often difficult to diagnose due to their pathologic and clinical heterogeneity. The key features …

Background Myelodysplastic syndromes (MDS) are a heterogeneous group of
hematopoietic disorders diagnosed using morphologic and clinical findings supported by …